• Department of Cardiovascular Surgery, First Affiliated Hospital of Air Force Medical University, Xi’an, Shaanxi 710032, P. R. China;
YANG Jian, Email: yangjian1212@hotmail.com
Export PDF Favorites Scan Get Citation

In recent years, transcatheter aortic valve replacement (TAVR) has developed rapidly in China, and the number and quality of operations have increased significantly. TAVR has become an important treatment strategy for patients with severe aortic stenosis and regurgitation following surgical aortic valve replacement. Prosthesis-patient mismatch (PPM) is one of the main complications after TAVR, but the incidence of TAVR-related PPM is significantly lower than surgical aortic valve replacement. Most studies believe that PPM has no significant effect on the clinical prognosis of most patients after TAVR, and only increases postoperative mortality in a specific population. This article will review the incidence, influencing factors, impact on clinical prognosis and related coping strategies of PPM after TAVR.

Citation: ZHAI Meng’en, MAO Yu, JIN Ping, XU Chennian, LIU Jincheng, LIU Yang, YANG Jian. Research status and treatment strategies of prosthesis-patient mismatch after transcatheter aortic valve replacement. West China Medical Journal, 2022, 37(4): 599-603. doi: 10.7507/1002-0179.202203119 Copy

  • Previous Article

    Research status of long-term durability in transcatheter aortic valve replacement
  • Next Article

    Effect of mitral regurgitation on transcatheter aortic valve replacement